

Polymerase Chain Reaction (PCR) Sequencer Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Polymerase Chain Reaction (PCR) sequencer market is experiencing significant growth, driven by advancements in molecular diagnostics and genomics. The market size is projected to reach approximately $5 billion by 2028, with key trends including increased adoption in clinical laboratories and research institutions, along with rising demand for personalized medicine.
Request Sample Report
◍ Thermo Fisher Scientific
◍ Generi Biotech
◍ ZyGEM
◍ Bio-Rad Laboratories
◍ GE Healthcare
◍ BD
◍ Abbott
The PCR sequencer market is competitive, with key players like Thermo Fisher Scientific, Bio-Rad Laboratories, and QIAGEN leading innovation and technology. These companies drive market growth through advanced products, strategic partnerships, and research collaborations, enhancing PCR applications in diagnostics and research. Notable sales revenue figures include:
- Thermo Fisher Scientific: $39 billion
- Bio-Rad Laboratories: $2.8 billion
- QIAGEN: $1.6 billion
◍ Beckman Coulter (Danaher Corporation)
◍ Affymetrix
◍ Sigma Aldrich Corporation
◍ Roche
◍ QIAGEN
◍ Agilent
◍ Analytik Jena
◍ Bioer
◍ Esco
◍ ELITech Group
Request Sample Report
Research
Diagnostic
Biopharma
Others
◍ Real Time PCR Sequencer
Standard PCR Sequencer
Digital PCR Sequencer
Others
Request Sample Report
Request Sample Report
$ X Billion USD